Latest Breaking News On - North star ambulatory assessment - Page 8 : comparemela.com

Murky road ahead for Duchenne gene therapy as confirmatory trial misses main goal

Murky road ahead for Duchenne gene therapy as confirmatory trial misses main goal
wsiltv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wsiltv.com Daily Mail and Mail on Sunday newspapers.

Doug ingramWarner brosDiscovery companyCable news network incDrug administrationSarepta therapeuticsJohns hopkinsNorth star ambulatory assessmentNews network

Sarepta Therapeutics Announces Third Quarter 2023 Financial Results and Recent Corporate Developments

Sarepta Therapeutics Announces Third Quarter 2023 Financial Results and Recent Corporate Developments
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United statesDoug ingramBiomarin pharmaceuticals incThermo fisher scientific incExchange commissionExchange agreementsRoche ltdSarepta therapeutics incDrug administrationTrademark officeUniversity of western australiaConference callTherapeutics announces third quarterRecent corporateRecent developmentNorth star ambulatory assessment

Even after primary miss, Sarepta to seek wider Elevidys approval

Even after primary miss, Sarepta to seek wider Elevidys approval
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

Louise rodino klapacDoug ingramAfter sareptaNorth star ambulatory assessment

Sarepta gene therapy for Duchenne misses main goal of key study

BioPharma

Doug ingramPeter marksLevi garrawayDrug administrationSarepta therapeuticNorth star ambulatory assessmentBiologics evaluationResaerch director peter marksSarepta mondayRoche chief medical officer levi garrawayClinical trialsGene therapy

Roche Says Late-Stage Muscular Dystrophy Trial Didn t Meet Main Goal

By Adria Calatayud Roche Holding said a late-stage trial evaluating its Elevidys drug in Duchenne muscular dystrophy didn t reach its primary goal of showing improvement in a measure of motor.

Adria calatayudRoche holdingNorth star ambulatory assessmentDow jones